Janney Montgomery Scott LLC lowered its stake in Exponent, Inc. (NASDAQ:EXPO - Free Report) by 5.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 50,831 shares of the business services provider's stock after selling 3,069 shares during the period. Janney Montgomery Scott LLC owned 0.10% of Exponent worth $4,529,000 at the end of the most recent quarter.
Several other institutional investors have also recently bought and sold shares of the stock. Heritage Family Offices LLP raised its stake in shares of Exponent by 3.8% during the fourth quarter. Heritage Family Offices LLP now owns 3,123 shares of the business services provider's stock worth $278,000 after buying an additional 114 shares during the last quarter. Mitchell & Pahl Private Wealth LLC lifted its stake in shares of Exponent by 3.7% in the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 5,961 shares of the business services provider's stock valued at $687,000 after purchasing an additional 214 shares during the period. Westside Investment Management Inc. bought a new position in shares of Exponent in the 3rd quarter worth $26,000. PNC Financial Services Group Inc. grew its stake in shares of Exponent by 2.2% during the third quarter. PNC Financial Services Group Inc. now owns 11,134 shares of the business services provider's stock worth $1,284,000 after purchasing an additional 239 shares during the period. Finally, GAMMA Investing LLC increased its holdings in Exponent by 64.6% in the third quarter. GAMMA Investing LLC now owns 624 shares of the business services provider's stock valued at $72,000 after purchasing an additional 245 shares during the last quarter. Institutional investors own 92.37% of the company's stock.
Exponent Stock Performance
NASDAQ:EXPO traded down $0.57 during mid-day trading on Friday, hitting $91.67. The company had a trading volume of 289,159 shares, compared to its average volume of 180,094. The firm has a market cap of $4.65 billion, a P/E ratio of 44.29 and a beta of 0.71. Exponent, Inc. has a fifty-two week low of $68.70 and a fifty-two week high of $115.75. The business's fifty day moving average is $92.73 and its two-hundred day moving average is $101.14.
Insiders Place Their Bets
In other Exponent news, Director Carol Lindstrom sold 1,039 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $96.32, for a total transaction of $100,076.48. Following the completion of the transaction, the director now owns 5,871 shares in the company, valued at approximately $565,494.72. This represents a 15.04 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, Director Paul R. Johnston sold 7,000 shares of the business's stock in a transaction dated Tuesday, November 12th. The shares were sold at an average price of $103.83, for a total value of $726,810.00. Following the completion of the sale, the director now owns 80,742 shares in the company, valued at approximately $8,383,441.86. This trade represents a 7.98 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 30,339 shares of company stock worth $3,103,065 over the last ninety days. 2.10% of the stock is currently owned by corporate insiders.
Exponent Profile
(
Free Report)
Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.
Read More

Before you consider Exponent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.
While Exponent currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.